Esculin was discovered to ameliorate cognitive impairment via the mitogen-activated protein kinase(MAPK) signaling pathway and exhibited antioxidative effects by reversing the inhibition of SOD activity and increasing MDA levels in a diabetic nephropathy mouse model, along with anti-inflammatory effects (64). Here, SOD1 is linked to Cognitive impairment.